Literature DB >> 12734409

Regulatory mechanisms of viral hepatitis B and C.

G Waris1, A Siddiqui.   

Abstract

Of all the hepatitis viruses, only the hepatitis B virus (HBV) and hepatitis C virus (HCV) cause chronic hepatitis, which can progress to cirrhosis and hepatocellular carcinoma. In this review, we discuss how these two biologically diverse viruses use common pathways to induce oxidative stress and activation of key transcription factors, known to be involved in inflammatory processes in cells. Activation of NF-kB and STAT-3 most likely contribute to the progression of viral infections to chronic hepatitis and liver oncogenesis associated with HBV and HCV infections. In this review, we focus on the mechanisms of action of HBx and HCV NS5A proteins in inducing intracellular events associated with the viral infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734409     DOI: 10.1007/bf02970150

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  97 in total

1.  Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential.

Authors:  Z Rahmani; K W Huh; R Lasher; A Siddiqui
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Oxidative stress during viral infection: a review.

Authors:  K B Schwarz
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

Review 3.  PKR: a new name and new roles.

Authors:  C G Proud
Journal:  Trends Biochem Sci       Date:  1995-06       Impact factor: 13.807

4.  Proteasome complex as a potential cellular target of hepatitis B virus X protein.

Authors:  J Huang; J Kwong; E C Sun; T J Liang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation.

Authors:  N Ali; A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.

Authors:  A Siddiqui; R Gaynor; A Srinivasan; J Mapoles; R W Farr
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

7.  The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.

Authors:  H S Chen; S Kaneko; R Girones; R W Anderson; W E Hornbuckle; B C Tennant; P J Cote; J L Gerin; R H Purcell; R H Miller
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

8.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.

Authors:  M Gale; B Kwieciszewski; M Dossett; H Nakao; M G Katze
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

10.  Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth.

Authors:  A K Ghosh; R Steele; K Meyer; R Ray; R B Ray
Journal:  J Gen Virol       Date:  1999-05       Impact factor: 3.891

View more
  23 in total

1.  Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.

Authors:  Yumei Du; Guangyao Kong; Xiaona You; Shuai Zhang; Tao Zhang; Yuen Gao; Lihong Ye; Xiaodong Zhang
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

Review 2.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein.

Authors:  Nicola Fiedler; Ellen Quant; Ludger Fink; Jianguang Sun; Ralph Schuster; Wolfram H Gerlich; Stephan Schaefer
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

4.  8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome.

Authors:  Shengmian Li; Xiaoling Wang; Yijuan Wu; Huijing Zhang; Lan Zhang; Cuiju Wang; Ruixing Zhang; Zhanjun Guo
Journal:  Oncol Lett       Date:  2011-11-10       Impact factor: 2.967

5.  Structural characterization of an intrinsically unfolded mini-HBX protein from hepatitis B virus.

Authors:  Si-Hyung Lee; Eun-Ji Cha; Ji-Eun Lim; Soon-Hwan Kwon; Do-Hyoung Kim; Hyeseong Cho; Kyou-Hoon Han
Journal:  Mol Cells       Date:  2012-07-20       Impact factor: 5.034

Review 6.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

7.  Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.

Authors:  Sheau-Fang Yang; Shen-Nien Wang; Chih-Fung Wu; Yao-Tsung Yeh; Chee-Yin Chai; Shih-Chang Chunag; Maw-Chang Sheen; King-Teh Lee
Journal:  J Clin Pathol       Date:  2006-08-10       Impact factor: 3.411

8.  Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition.

Authors:  Satoshi Mamori; Tadashi Asakura; Kiyoshi Ohkawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

Review 9.  Core promoter: a critical region where the hepatitis B virus makes decisions.

Authors:  Jorge Quarleri
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance.

Authors:  Vittorio Di Maso; Claudio Avellini; Lory Saveria Crocè; Natalia Rosso; Franco Quadrifoglio; Laura Cesaratto; Erika Codarin; Giorgio Bedogni; Carlo Alberto Beltrami; Gianluca Tell; Claudio Tiribelli
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.